|
|
Article: Low-dose corticosteroid targets acute allergic conjunctivitis
- Article from:
- Ophthalmology Times
- Article date:
- September 1, 2005
- Author:
CopyrightCopyright Advanstar Communications, Inc. Sep 1, 2005. Provided by ProQuest LLC. (Hide copyright information)
|
Seasonal, perennial allergies
Low-dose corticosteroid targets acute allergic conjunctivitis
Agent relieves symptoms immediately with tapered dosing regimen
Reviewed by Ayman Matta, MD, PC, FACS
Orangeburg, NY-The low-dose modified corticosteroid loteprednol etabonate ophthalmic suspension 0.2% (Alrex, Bausch & Lomb) is effectively used during the acute phase of seasonal allergic conjunctivitis, according to Ayman Matta, MD, PC, FACS.
Loteprednol is particularly effective when an antihistaminic medication or combination mast cell stabilizer and antihistamine has not completely controlled patients' symptoms, said Dr. Matta, director of the New York Eye Institute/ Langerman Matta Eye ...